Project Details
Description
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Oral Brepocitinib in Adults with Dermatomyositis
| Status | Active |
|---|---|
| Effective start/end date | 11/2/22 → 7/31/27 |
Funding
- PRIOVANT THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.